Dimitar T. Atanasov

Dimitar T. Atanasov

Auto-generated profile, based on publicly available information

Dimitar T. Atanasov

Med Univ Plovdiv, Fac Dent Med, Dept Oral Surg, 3 Hristo Botev Blvd, Plovdiv 4000, Bulgaria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2019 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
TSTanya I. Sbirkova
Tanya I. Sbirkova
DNDeyan Neychev
Deyan Neychev
Ralitsa RaychevaRalitsa Raycheva
Ralitsa Raycheva
DADimitar T. Atanasov
Dimitar T. Atanasov

29 January 2019 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
DNDeyan Neychev
Deyan Neychev
RCRadka B. Cholakova
Radka B. Cholakova
TSTanya I. Sbirkova
Tanya I. Sbirkova
SKStanimir N. Kisselov
Stanimir N. Kisselov
SBSvitlana Y. Bachurska
Svitlana Y. Bachurska
DADimitar T. Atanasov
Dimitar T. Atanasov

5 May 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
ADAtanaska Spasova Dinkova
Atanaska Spasova Dinkova
DADimitar T. Atanasov
Dimitar T. Atanasov
LVLudmila G. Vladimirova-Kitova
Ludmila G. Vladimirova-Kitova

29 November 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
ADAtanaska Spasova Dinkova
Atanaska Spasova Dinkova
DADimitar T. Atanasov
Dimitar T. Atanasov
LVLudmila G. Vladimirova-Kitova
Ludmila G. Vladimirova-Kitova
Purpose: Cardiovascular diseases are leading cause of mortality and disability worldwide. Major role in the treatment and prophylaxis of these diseases and their complications have antiplatelet and anticoagulation drugs. Routine practice in the past was an interruption of antiplatelet and anticoagulant medication before dental extraction. Today most authors and dental associations recommend maintaining therapeutic levels of antithrombotic drugs in single or multiple teeth extractions due to the fact that the risk of serious thromboembolic complications outweighs the risk of bleeding. The aim of the present study is to determine the opinion and approach of the General Practitioners in Bulgaria regarding therapy with Aspirin, Clopidogrel and Acenocoumarol in patients undergoing dental extractions. \ud Material and Method: 282 General Practitioners were interviewed for their approach to the antithrombotic therapy with Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing dental extractions. \ud Results: There is no consensus and an established protocol on the cessation of Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom), and for what period of time before dental extraction.\ud Conclusion: Among General Practitioners in Bulgaria there is no approved protocol regarding administration of Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing teeth extraction

31 October 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
ADAtanaska Spasova Dinkova
Atanaska Spasova Dinkova
DADimitar Atanasov
Dimitar Atanasov
LVLyudmila Vladimirova-Kitova
Lyudmila Vladimirova-Kitova
SYStoyan Yankov
Stoyan Yankov
Purpose: Cardiovascular diseases are the leading cause of mortality and disability worldwide. Major role in the treatment and prophylaxis of these diseases and their complications has antiplatelet and anticoagulation therapy. Routine practice in the past was an interruption of antiplatelet and anticoagulant medication before dental extraction. Today most authors and dental associations recommend maintaining therapeutic levels of antithrombotic drugs in single or multiple teeth extractions due to the fact that the risk of serious embolic complications outweighs the risk of bleeding. The aim f the present study is to determine the opinion and approach of cardiologists in Bulgaria regarding therapy with Aspirin, Clopidogrel and Acenocoumarol in patients undergoing dental extractions. \ud Material and Method: 222 cardiologists were interviewed about their approach in terms of antithrombotic therapy with acetylsalicylic acid (Aspirin), Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing dental extractions. \ud Results: There is no consensus and an established protocol the cessation of enrolled medications and how long before dental extraction.\ud Conclusion: There is no approved protocol regarding administration of acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing teeth extraction. A large number of thromboembolic complications due to interruption of the therapy has been reporte